Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Patent
1994-08-18
1996-11-19
Rotman, Alan L.
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
546177, C07D21520, C07D21522, C07D215227
Patent
active
055764371
ABSTRACT:
The subject invention involves methods of treating nasal congestion comprising administration, to a human or lower animal in need of such treatment of a safe and effective amount of a compound having the following structure: ##STR1## wherein: (a) R is unsubstituted C.sub.1 -C.sub.3 alkanyl or alkenyl; and
REFERENCES:
patent: 3890319 (1975-06-01), Danielewicz et al.
patent: 4029792 (1977-06-01), Danielewicz et al.
patent: 4036976 (1977-07-01), Neumann
patent: 4217356 (1980-08-01), Neumann
patent: 4398028 (1983-08-01), Neumann
patent: 5021416 (1991-06-01), Gluchowski
patent: 5091528 (1992-02-01), Gluchowski
patent: 5180721 (1993-01-01), Burke
patent: 5231096 (1993-07-01), Gluchowski et al.
patent: 5281591 (1994-01-01), Burke
Cambridge, D., "UK-14,304, A Potent and Selective .alpha..sub.2 -Agonist for the Characterization of .alpha.-Adrenoceptor Subtypes", European Journal of Pharmacology, vol. 72, pp. 413-415 (1981).
Chapleo, C. B., J. C. Doxey, P. L. Myers, M. Myers, C. F. C. Smith and M. R. Stillings, "Effect of 1,4-Dioxanyl Substitution on the Adrenergic Activity of some Standard .alpha.-Adrenoreceptor Agents", European Journal of Medicinal Chemistry, vol. 24, pp. 619-622 (1989).
Chapleo, C. B., R. C. M. Butler, D. C. England, P. L. Myers, A. G. Roach, C. F. C. Smith, M. R. Stillings and I. F. Tulloch, "Heteroaromatic Analogues of the .alpha..sub.2 -Adrenoreceptor Partial Agonist Clondine", J. Med. Chem., vol. 32, pp. 1627-1630 (1989).
Clare, K. A., M. C. Scrutton and N. T. Thompson, "Effects of .alpha..sub.2 -Adrenoreceptor Agonists and of Related Compounds on Aggregation of, and on Adenylate Cyclose Activity in, Human Platelets", Br. J. Pharmacl, vol. 82, pp. 467-476 (1984).
Timmermans, P. B. M. W. M. and P. A. van Zwieten, ".alpha..sub.2 -Adrenoceptor Agonists and Antagonists", Drugs of the Future, vol., 9, No. 1, pp. 41-55 (Jan. 1984).
Timmermans, P. B. M. W. M. A. T. Chiu and M. J. M. C. Thoolen, "12,1 .alpha..sub.2 -Adrenergic Receptors", Comprehensive Medicinal Chemistry, vol. 3, Membranes & Receptors, pp. 133-185 (1990).
Timmermans, P. B. M. W. M. A. de Jonge, M. J. M. C. Thoolen, B. Wilffert, H. Batink and P. A. van Zwieten, "Quantitative Relationships between" .alpha..sub.2 -Adrenergic Activity and Binding Affinity of .alpha..sub.2 -Adrenoceptor Agonists and Antagonists, J. Med. Chem., vol. 27, pp. 495-503 (1984).
Megens, A. A. H. P., J. E. Leysen, F. H. L. Awouters and C. J. E. Niemegeers, "Ruther Validation of In Vivo and In Vitro Pharmacological Procedures for Assessing the" .alpha..sub.2/ .alpha..sub.1 -Selectivity of Test Compounds: (2) .alpha.-Adrenoceptor Agonists, European Journal of Pharmacology, vol. 129, pp. 57-64 (1986).
Van Meel, J. C. A., A. de Jonge, P. B. M. W. M. Timmermans and P. A. van Zwieten, "Selectivity of Some Alpha Adrenoceptor Agonists for Peripheral Alpha-1 and Alpha-2 Adrenoceptors in the Normotensive Rat", The Journal of Pharmacology and Experimental Therapeutics, vol. 219, pp. 760-767 (1981).
Bogdan Sophie E.
Cupps Thomas L.
Clark Karen F.
Graff Mick B.
Hake Richard A.
Rotman Alan L.
The Procter & Gamble & Company
LandOfFree
7-(2-imidazolnylamino) quinoline compounds useful as alpha-2 adr does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 7-(2-imidazolnylamino) quinoline compounds useful as alpha-2 adr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 7-(2-imidazolnylamino) quinoline compounds useful as alpha-2 adr will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-542023